Gritstone Oncology (GRTS) PT Raised to $24 at H.C. Wainwright on Second Generation COVID Vaccine Development
Tweet Send to a Friend
H.C. Wainwright analyst Sean Lee raised the price target on Gritstone Oncology (NASDAQ: GRTS) to $24.00 (from $16.00) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
